Cardiovascular Drugs Practice Questions

Q: Which vitamin is given in Type 2B Familial Hyperlipidemia?

Nicotinic acid. **Explanation:** **Nicotinic Acid (Vitamin B3/Niacin)** is the correct answer because it is a potent lipid-lowering agent [1]. In **Type 2B Familial Hyperlipidemia** (Combined Hyperlipidemia), there is an elevation of both LDL and VLDL (and consequently, triglycerides). **Mechanism of Action:** Niacin acts by inhibiting the enzyme **hormone-sensitive lipase** in adipose tissue. This reduces the breakdown of triglycerides into free fatty acids (FFA). Since the liver uses FFA to synthesize VLDL, a decrease in FFA leads to: 1. Decreased VLDL synthesis. 2. Decreased LDL levels (as LDL is a metabolic product of VLDL). 3. Increased HDL levels (by decreasing its clearance) [1]. This makes it highly effective for Type 2B, where both cholesterol and triglycerides are elevated [2]. **Why other options are incorrect:** * **Pantothenic acid (B5), Riboflavin (B2), and Thiamine (B1):** While these are essential water-soluble vitamins acting as co-factors in various metabolic pathways (e.g., Krebs cycle, decarboxylation), they do not possess significant lipid-lowering properties and have no therapeutic role in treating hyperlipidemias. **High-Yield Clinical Pearls for NEET-PG:** * **Most Potent:** Niacin is the most effective drug for **increasing HDL** levels. * **Side Effects:** The most common side effect is **cutaneous flushing** (mediated by Prostaglandin D2/E2; prevented by **Aspirin**). * **Metabolic Risks:** It can cause **hyperuricemia** (precipitating gout), **hyperglycemia** (caution in diabetics), and hepatotoxicity. * **Type 2B Phenotype:** Characterized by increased LDL + VLDL (Apo B-100 elevation).

Q: Digoxin toxicity is precipitated by all except?

Hepatic disease. **Explanation:** Digoxin is a cardiac glycoside with a narrow therapeutic index, meaning small changes in its metabolism or the body’s internal environment can easily lead to toxicity [3]. **Why Hepatic Disease is the Correct Answer:** Digoxin is primarily excreted **unchanged by the kidneys (approx. 60-80%)** [3]. It undergoes minimal hepatic metabolism. Therefore, hepatic impairment does not significantly affect digoxin levels and does not precipitate toxicity. In contrast, drugs like Digitoxin are metabolized by the liver and would be affected by hepatic disease [3]. **Analysis of Incorrect Options:** * **Electrolyte Disturbance:** This is the most common trigger. **Hypokalemia** is the classic precipitant because K+ and Digoxin compete for the same binding site on the Na+/K+ ATPase pump. Low K+ allows more Digoxin to bind. Hypomagnesemia and Hypercalcemia also increase toxicity risk. * **Acute Myocardial Infarction (MI):** Ischemic myocardium is more sensitive to the arrhythmogenic effects of Digoxin. The damaged tissue has altered electrical stability, lowering the threshold for Digoxin-induced arrhythmias. * **Renal Disease:** Since Digoxin is primarily cleared by the kidneys, any decrease in Glomerular Filtration Rate (GFR) leads to drug accumulation and toxicity [3]. Dose adjustment is mandatory in renal failure [3]. **High-Yield Clinical Pearls for NEET-PG:** * **Most common ECG finding in toxicity:** Ventricular Bigeminy [2]. * **Most characteristic ECG finding:** Bidirectional Ventricular Tachycardia. * **Early signs of toxicity:** Gastrointestinal symptoms (anorexia, nausea, vomiting). * **Visual disturbance:** Xanthopsia (yellowish-green vision). * **Antidote:** Digoxin Immune Fab (Digibind). * **Drug Interactions:** Quinidine, Verapamil, and Amiodarone increase Digoxin levels by displacing it from tissue binding sites and reducing renal clearance [1].

Q: What effect does digitalis have when given in atrial flutter?

Atrial fibrillation. Digitalis (Digoxin) is a unique anti-arrhythmic agent that exerts its effects primarily through the enhancement of vagal tone (parasympathomimetic effect). **Why Atrial Fibrillation is the Correct Answer:** In **Atrial Flutter**, the atria beat at a rapid, organized rate (typically 250–350 bpm). Digitalis acts by **shortening the atrial refractory period** and increasing the conduction velocity in the atrial muscle [1]. This "pro-arrhythmic" effect on the atria tends to convert the organized, large-circuit reentry of flutter into the disorganized, multiple-micro-reentry circuits characteristic of **Atrial Fibrillation (AF)** [1, 2]. While this might seem counterintuitive, converting flutter to AF is often clinically acceptable because Digitalis simultaneously **increases the refractory period of the AV node** [1]. This slows the ventricular rate, protecting the ventricles from the rapid atrial impulses and providing symptomatic relief. **Analysis of Incorrect Options:** * **B. Atrial Tachycardia:** Digitalis is used to treat certain supraventricular tachycardias; it does not typically convert flutter into a simple tachycardia. * **C. Atrial Asystole:** Digitalis does not cause the atria to stop beating entirely; its effect is to change the rhythm, not induce standstill. * **D. Atrial Bigeminy:** While Digitalis toxicity can cause ventricular bigeminy (due to increased automaticity), it is not the characteristic outcome of treating atrial flutter. **High-Yield NEET-PG Pearls:** * **Mechanism:** Digoxin inhibits the Na+/K+ ATPase pump, but its anti-arrhythmic effect is via **vagal stimulation**. * **ECG Changes:** Look for the "reverse tick" or "Sagging ST segment" (Digitalis effect). * **Toxicity:** The most common arrhythmia in Digoxin toxicity is **PVCs**, but the most characteristic/pathognomonic is **PAT with AV block**. * **Electrolytes:** Hypokalemia, hypomagnesemia, and hypercalcemia predispose to Digoxin toxicity.

Q: Fenoldopam is an?

D1 Agonist. **Explanation:** **Fenoldopam** is a rapid-acting vasodilator used primarily in the management of hypertensive emergencies. **Why D1 Agonist is Correct:** Fenoldopam is a **selective post-synaptic Dopamine-1 (D1) receptor agonist**. Activation of D1 receptors leads to the stimulation of adenylyl cyclase, increasing intracellular cAMP. This results in potent arteriolar vasodilation. A unique and high-yield feature of Fenoldopam is its ability to cause **renal vasodilation**, which increases renal blood flow and promotes natriuresis (sodium excretion) and diuresis. This makes it particularly useful in hypertensive patients with renal impairment. **Why other options are incorrect:** * **D2 Agonist:** D2 receptors are primarily located in the CNS and presynaptic nerve terminals. Agonists (like Bromocriptine) are used in Parkinson’s disease or hyperprolactinemia, not for acute blood pressure control. * **D2 Antagonist:** These drugs (like Metoclopramide or Haloperidol) are used as anti-emetics or antipsychotics and can actually cause side effects like extrapyramidal symptoms or hyperprolactinemia. * **D1 Antagonist:** Blocking D1 receptors would inhibit vasodilation and decrease renal perfusion, which is the opposite of the desired effect in a hypertensive crisis. **High-Yield Clinical Pearls for NEET-PG:** * **Indication:** Hypertensive emergencies, especially in patients with **acute kidney injury (AKI)** or renal insufficiency. * **Route:** Administered via continuous **IV infusion** due to a very short half-life (~5–10 minutes). * **Side Effects:** Reflex tachycardia, headache, flushing, and a dose-dependent **increase in intraocular pressure** (use with caution in glaucoma). * **Comparison:** Unlike Sodium Nitroprusside, Fenoldopam does not carry the risk of cyanide or thiocyanate toxicity.

Q: Which calcium channel sensitizer is approved for the treatment of congestive heart failure?

Levosimendan. **Explanation:** **Levosimendan** is the correct answer because it is a unique "Inodilator" that acts primarily as a **calcium channel sensitizer**. It binds to cardiac troponin C in a calcium-dependent manner, increasing the sensitivity of the contractile apparatus to existing intracellular calcium. This enhances myocardial contractility (inotropy) without increasing intracellular calcium levels, thereby avoiding the risk of arrhythmias and increased myocardial oxygen demand associated with traditional inotropes like Dobutamine. Additionally, it opens ATP-sensitive potassium channels, leading to peripheral vasodilation. **Analysis of Incorrect Options:** * **Nesiritide:** This is a recombinant form of human B-type Natriuretic Peptide (BNP). It acts via cGMP to cause vasodilation and natriuresis but does not have calcium-sensitizing properties. * **Vasopressin:** An antidiuretic hormone (ADH) analogue used primarily as a vasoconstrictor in distributive shock; it would worsen heart failure by increasing afterload. * **Nitroprusside:** A potent vasodilator that acts by releasing Nitric Oxide (NO). It reduces both preload and afterload but has no direct effect on cardiac contractility or calcium sensitivity. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Levosimendan increases inotropy *without* increasing myocardial oxygen consumption ($MVO_2$). * **Dual Action:** It is an **Inodilator** (Inotrope + Vasodilator). * **Indication:** Short-term management of acutely decompensated severe chronic heart failure. * **Side Effects:** Hypotension (due to vasodilation) and headache. * **Comparison:** Unlike Milrinone (a PDE-3 inhibitor), Levosimendan does not significantly increase the risk of calcium-overload-induced arrhythmias.

Q: Monday disease is associated with exposure to which class of drugs?

Nitrates. **Explanation:** **Monday Disease** is a classic phenomenon associated with industrial exposure to **Nitrates** (specifically nitroglycerin and ethylene glycol dinitrate) in explosives factories. **Why Nitrates are the correct answer:** Workers in these factories develop a high degree of **tolerance** to the vasodilatory effects of nitrates during the workweek. By the weekend, when they are away from the exposure, this tolerance is lost. Upon returning to work on **Monday**, the re-exposure causes sudden, intense vasodilation, leading to severe headaches (due to meningeal artery dilation), dizziness, and tachycardia. This cycle of losing and regaining tolerance is the hallmark of "Monday Disease." **Why other options are incorrect:** * **Beta blockers:** These drugs are used to manage heart rate and blood pressure; they do not cause industrial tolerance-withdrawal syndromes like nitrates. * **Calcium channel blockers (CCBs):** While CCBs cause vasodilation, they are not associated with the rapid tolerance and "weekend-reset" phenomenon seen in industrial nitrate exposure. * **Potassium channel openers:** Drugs like Minoxidil or Nicorandil cause vasodilation but are not used in the industrial manufacturing processes linked to this specific occupational hazard. **High-Yield Clinical Pearls for NEET-PG:** 1. **Tolerance Management:** To prevent nitrate tolerance in clinical practice, a **"Nitrate-free interval"** of 8–12 hours (usually at night) is mandatory. 2. **Mechanism:** Nitrates work by releasing **Nitric Oxide (NO)**, which increases **cGMP**, leading to dephosphorylation of myosin light chains and vascular smooth muscle relaxation. 3. **Drug Interaction:** Nitrates are strictly contraindicated with **Sildenafil** (PDE-5 inhibitors) as the combination can cause life-threatening hypotension.

Q: Which class of antihypertensive medications is primarily used in the management of angina pectoris?

Beta blocker. **Explanation:** **Why Beta Blockers are the Correct Choice:** Beta-blockers (e.g., Atenolol, Metoprolol) are the first-line antihypertensive agents for patients with comorbid stable angina. Their primary mechanism involves blocking $\beta_1$ receptors in the heart, leading to a decrease in heart rate (**negative chronotropy**) and myocardial contractility (**negative inotropy**). This significantly reduces **myocardial oxygen demand**. Additionally, by slowing the heart rate, they increase the duration of diastole, which improves coronary perfusion. **Analysis of Incorrect Options:** * **Alpha-blockers (A):** These cause peripheral vasodilation. While they lower blood pressure, they often trigger **reflex tachycardia**, which increases oxygen demand and can worsen anginal symptoms. * **Diuretics (C):** These reduce blood pressure by decreasing plasma volume. They have no direct effect on myocardial oxygen supply or demand and are not used for the management of angina. * **ACE Inhibitors (D):** These are excellent for hypertension, heart failure, and diabetic nephropathy. While they provide cardioprotection post-MI, they do not have direct anti-anginal properties (they don't reduce heart rate or contractility). **High-Yield Clinical Pearls for NEET-PG:** * **DOC for Angina:** Beta-blockers are the drugs of choice for the chronic prophylaxis of stable angina. * **Contraindication:** Avoid beta-blockers in **Prinzmetal (variant) angina**, as they can lead to unopposed alpha-mediated coronary vasospasm. * **Goal:** In angina patients, the dose should be titrated to maintain a resting heart rate of 55–60 bpm. * **Sudden Withdrawal:** Never stop beta-blockers abruptly; it can precipitate rebound hypertension or myocardial infarction due to receptor up-regulation.

Question 1

Which vitamin is given in Type 2B Familial Hyperlipidemia?

Accepted Answer

Nicotinic acid

Answer

Pantothenic acid

Answer

Riboflavin

Answer

Thiamine

Question 2

Digoxin is contraindicated in which of the following conditions?

Accepted Answer

Hypertrophic obstructive cardiomyopathy

Answer

Supraventricular tachycardia

Answer

Atrial fibrillation

Answer

Congestive heart failure

Question 3

Digoxin toxicity is precipitated by all except?

Accepted Answer

Hepatic disease

Answer

Electrolyte disturbance

Answer

Acute myocardial infarction

Answer

Renal disease

Question 4

What is the drug of choice in paroxysmal supraventricular tachycardia?

Accepted Answer

Adenosine

Answer

Digoxin

Answer

Nifedipine

Answer

Esmolol

Question 5

What effect does digitalis have when given in atrial flutter?

Accepted Answer

Atrial fibrillation

Answer

Atrial tachycardia

Answer

Atrial asystole

Answer

Atrial bigeminy

Question 6

Fenoldopam is an?

Accepted Answer

D1 Agonist

Answer

D2

Answer

D2 Antagonist

Question 7

Pancuronium differs from tubocurarine in that it:

Accepted Answer

Can cause a rise in blood pressure on rapid intravenous injection

Answer

Is a depolarizing blocker

Answer

Its action is not reversed by neostigmine

Answer

Causes marked histamine release

Question 8

Which calcium channel sensitizer is approved for the treatment of congestive heart failure?

Accepted Answer

Levosimendan

Answer

Nesitritide

Answer

Vasopressin

Answer

Nitroprusside

Question 9

Monday disease is associated with exposure to which class of drugs?

Accepted Answer

Nitrates

Answer

Beta blockers

Answer

Calcium channel blockers

Answer

Potassium channel openers

Question 10

Which class of antihypertensive medications is primarily used in the management of angina pectoris?

Accepted Answer

Beta blocker

Answer

Alpha blocker

Answer

Diuretics

Answer

ACE inhibitors

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?